Research Analysts’ Recent Ratings Changes for 4D Molecular Therapeutics (FDMT)
Several analysts have recently updated their ratings and price targets for 4D Molecular Therapeutics (NASDAQ: FDMT): 11/21/2024 – 4D Molecular Therapeutics is now covered by analysts at Morgan Stanley. They set an “underweight” rating and a $8.00 price target on the stock. 11/14/2024 – 4D Molecular Therapeutics had its price target lowered by analysts at […]
More Stories
Treasury Secretary Says US Can Easily Cover Any Tariff Refunds
By Jack Phillips Treasury Secretary Scott Bessent said that his department can easily cover any refunds related to tariffs if...
Conrad Black: How US Action Against the Iranian Regime Could Play Out
By Conrad Black The world is waiting for President Trump to bring the horrible and sanguinary disaster of the last...
Judge Blocks Parts of Trump’s Election Order on Citizenship Proof, Ballot Deadline Rules
By Tom Ozimek A federal judge has blocked key parts of President Donald Trump’s election-related executive order in Washington state...
What is a Policy Management System? 8 Best Policy Management Software
Are you also searching for software to automate your company’s policy? In this article, I’ll share details about the policy...
Murder of Renee Nicole Good Raised Questions on Trump’s Immigration Policy
Who is Renee Nicole Good? Why suddenly everyone’s eyes are on the US? Renee Nicole is a poet, writer, wife,...
Musk Says X’s New Algorithm Will Be Open Source in 6 Days
By Jacob Burg Elon Musk said on Jan. 10 that his X social media platform would open its new algorithm...